Laboratory News and Research

RSS

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

Researchers at University of California San Diego School of Medicine have discovered one way in which SARS-CoV-2, the coronavirus that causes COVID-19, hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause disease.

29 Apr 2021

New exosome-based therapeutic strategy to potentially treat late-stage colorectal cancer

In a recent discovery by University of Minnesota Medical School, researchers uncovered a new way to potentially target and treat late-stage colorectal cancer - a disease that kills more than 50,000 people each year in the United States.

29 Apr 2021

Texas A&M AgriLife receives grant to support research on bacteriophage therapy

The National Institute of Allergy and Infectious Diseases, NIAID, part of the National Institutes of Health, NIH, has awarded $2.5 million in grants to support research on bacteriophage therapy, and Texas A&M AgriLife Research is among the grant recipients.

29 Apr 2021

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.

29 Apr 2021

Researchers apply 'kitchen sink approach' to produce 16 high-quality reference genomes

The flightless kakapo of New Zealand is in trouble. The world's heaviest parrot--representing one of the most ancestral branches of the parrot family tree--is nearly extinct, with barely 200 adults plodding the underbrush of four small islands.

29 Apr 2021

New collaboration to study early detection of developmental differences in children

The University of Washington's School of Medicine Brotman Baty Institute for Precision Medicine is collaborating with Illumina, Inc. and GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company, to study early detection of developmental differences in children.

29 Apr 2021

Using light-activated 3D printing to manufacture self-healing hydrogels with complex architectures

The scientific community is focusing its research into the multiple applications of Hydrogels, polymeric materials which contains a large amount of water, that have the potential to reproduce the features of biological tissues.

29 Apr 2021

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies

A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer.

29 Apr 2021

SCAI releases expert consensus statement on best practices in cardiac catheterization lab

The Society for Cardiovascular Angiography and Interventions has released an expert consensus statement providing cardiologists, cath lab directors, and hospital leadership guidance for contemporary cath lab standards.

28 Apr 2021

New method could be used to develop more effective treatments for cancer, metabolic disorders

Researchers from the University of Copenhagen have developed a new method that makes it possible to control human hormones and metabolism.

28 Apr 2021

Cognitive neuroscience could inspire the development of emotionally intelligent robots

Human beings have the ability to recognize emotions in others, but the same cannot be said for robots. Although perfectly capable of communicating with humans through speech, robots and virtual agents are only good at processing logical instructions, which greatly restricts human-robot interaction (HRI).

28 Apr 2021

Researchers develop first 3D organoid models of the pancreas from human stem cells

This year, more than 60,000 adults in the United States will be diagnosed with pancreatic cancer and, statistically, as few as 10 percent will survive five years after diagnosis, according to the American Cancer Society.

28 Apr 2021

Purified exosomal product accelerates wound healing in preclinical models

Difficult-to-treat, chronic wounds in preclinical models healed with normal scar-free skin after treatment with an acellular product discovered at Mayo Clinic.

28 Apr 2021

Topical therapy can help safely reduce side effect of cancer treatment

Patients with advanced colorectal cancer may be spared from a toxic side effect caused by a type of targeted therapy used to treat the cancer with the help of another drug normally used to treat melanoma, according to a study led by researchers at the UCLA Jonsson Comprehensive Cancer Center and Memorial Sloan Kettering Cancer Center.

28 Apr 2021

Researchers suggest new approach to build a 'nanopore' biosensor for detecting specific molecules

Researchers have spent more than three decades developing and studying miniature biosensors that can identify single molecules. In five to 10 years, when such devices may become a staple in doctors' offices, they could detect molecular markers for cancer and other diseases and assess the effectiveness of drug treatment to fight those illnesses.

28 Apr 2021

Pfizer-BioNTech (BNT162b2) vaccine successfully curbs COVID-19 in Israel

Researchers in Israel have shown that three national programs established by the Israeli government have successfully reduced cases of severe coronavirus disease 2019 (COVID-19) and death caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

27 Apr 2021

New breakthrough method for quickly, accurately diagnosing cardiac arrhythmias

Researchers from Belgium, the Netherlands, Russia, and Italy have developed a breakthrough method for quickly, accurately, and reliably diagnosing cardiac arrhythmias.

27 Apr 2021

Researchers design "nanotraps" to capture and destroy SARS-CoV-2 viruses

Researchers at the Pritzker School of Molecular Engineering at the University of Chicago have designed a completely novel potential treatment for COVID-19: nanoparticles that capture SARS-CoV-2 viruses within the body and then use the body's own immune system to destroy it.

27 Apr 2021

Benefits of deploying the AstraZeneca vaccinations for COVID-19 greatly outweigh its risks

The AstraZeneca COVID-19 vaccine is suspected of being linked to a small number of deep vein thrombosis (DVT) cases, which recently emerged within Europe as millions of people received vaccinations. This led several countries to suspend AstraZeneca injections and investigate the causal links to DVT.

27 Apr 2021

SARS-CoV-2 suppresses the immune response in the gut

In an effort to determine the potential for COVID-19 to begin in a person's gut, and to better understand how human cells respond to SARS-CoV-2, the scientists used human intestinal cells to create organoids - 3D tissue cultures derived from human cells, which mimic the tissue or organ from which the cells originate.

27 Apr 2021

Laboratory News and Research

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

New exosome-based therapeutic strategy to potentially treat late-stage colorectal cancer

Texas A&M AgriLife receives grant to support research on bacteriophage therapy

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Researchers apply 'kitchen sink approach' to produce 16 high-quality reference genomes

New collaboration to study early detection of developmental differences in children

Using light-activated 3D printing to manufacture self-healing hydrogels with complex architectures

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies

SCAI releases expert consensus statement on best practices in cardiac catheterization lab

New method could be used to develop more effective treatments for cancer, metabolic disorders

Cognitive neuroscience could inspire the development of emotionally intelligent robots

Researchers develop first 3D organoid models of the pancreas from human stem cells

Purified exosomal product accelerates wound healing in preclinical models

Topical therapy can help safely reduce side effect of cancer treatment

Researchers suggest new approach to build a 'nanopore' biosensor for detecting specific molecules

Pfizer-BioNTech (BNT162b2) vaccine successfully curbs COVID-19 in Israel

New breakthrough method for quickly, accurately diagnosing cardiac arrhythmias

Researchers design "nanotraps" to capture and destroy SARS-CoV-2 viruses

Benefits of deploying the AstraZeneca vaccinations for COVID-19 greatly outweigh its risks

SARS-CoV-2 suppresses the immune response in the gut

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo